Trademark: 97779623
Word
DRIZALMA SPRINKLE
Status Date
Tuesday, May 7, 2024
Filing Date
Friday, February 3, 2023
Published for Opposition
Tuesday, September 26, 2023
5 Pharmaceutical preparations for the treatment of neurologic disorders, disorders of the nervous system, mental illness, major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, chronic musculoskeletal pain
The mark consists of the stylized wording "DRIZALMA SPRINKLE" presented horizontally, with three dots forming in part the vertical side of the letter "D".
Color is not claimed as a feature of the mark.
The wording "DRIZALMA" has no meaning in a foreign language.
"SPRINKLE"
Feb 7, 2023
New Application Entered
Feb 23, 2023
New Application Office Supplied Data Entered
Feb 24, 2023
Notice Of Design Search Code E-Mailed
Aug 12, 2023
Assigned To Examiner
Aug 17, 2023
Examiners Amendment -Written
Aug 17, 2023
Examiners Amendment E-Mailed
Aug 17, 2023
Notification Of Examiners Amendment E-Mailed
Aug 17, 2023
Examiner's Amendment Entered
Aug 17, 2023
Approved For Pub - Principal Register
Sep 6, 2023
Notification Of Notice Of Publication E-Mailed
Sep 26, 2023
Published For Opposition
Sep 26, 2023
Official Gazette Publication Confirmation E-Mailed
Nov 21, 2023
Noa E-Mailed - Sou Required From Applicant
May 7, 2024
Sou Teas Extension Received
May 7, 2024
Sou Extension 1 Filed
May 7, 2024
Sou Extension 1 Granted
May 8, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
